Kindred Biosciences Announces Closing of Public Offering of Common Stock and the Full Exercise of Underwriters’ Option to Purchase Additional Shares 글 내용 전체보기
Attune Pharmaceuticals Announces $23M Series B Financing to Advance ATN-249 for the Treatment of HAE 글 내용 전체보기